{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:44:54Z","timestamp":1764402294398},"reference-count":34,"publisher":"Elsevier BV","issue":"17-18","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.vaccine.2003.11.044","type":"journal-article","created":{"date-parts":[[2003,12,30]],"date-time":"2003-12-30T12:05:34Z","timestamp":1072785934000},"page":"2226-2233","source":"Crossref","is-referenced-by-count":55,"title":["Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants"],"prefix":"10.1016","volume":"22","author":[{"given":"F","family":"Zepp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Knuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U","family":"Heininger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Collard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Habermehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Schuerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"S\u00e4nger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.11.044_BIB1","unstructured":"Combination vaccines for childhood immunization. MMWR Recomm Rep 1999;48(RR-5):1\u201314."},{"issue":"RR-2","key":"10.1016\/j.vaccine.2003.11.044_BIB2","first-page":"1","article-title":"General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP)","volume":"51","author":"Atkinson","year":"2002","journal-title":"MMWR CDC Surveill. Summ."},{"issue":"3 Pt 2","key":"10.1016\/j.vaccine.2003.11.044_BIB3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1542\/peds.96.3.557","article-title":"Comparison of 13 acellular pertussis vaccines: adverse reactions","volume":"96","author":"Decker","year":"1995","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.vaccine.2003.11.044_BIB4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00006454-199405000-00003","article-title":"Combination vaccines: hopes and challenges","volume":"13","author":"Edwards","year":"1994","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"2","key":"10.1016\/j.vaccine.2003.11.044_BIB5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00003495-199754020-00001","article-title":"An overview of the status of acellular pertussis vaccines in practice","volume":"54","author":"Lopez","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.vaccine.2003.11.044_BIB6","unstructured":"Certification of poliomyelitis eradication\u2014European Region, June 2002. MMWR Morb Mortal Wkly Rep 2002;51(26):572\u20134."},{"key":"10.1016\/j.vaccine.2003.11.044_BIB7","unstructured":"Progress towards the global eradication of poliomyelitis, 2001. Wkly Epidemiol Rec 2002;77(13):98\u2013107."},{"key":"10.1016\/j.vaccine.2003.11.044_BIB8","unstructured":"Global Programme for Vaccines and Immunization (GPV). The WHO position paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol Rec 1998;73(10):64\u20138."},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2003.11.044_BIB9","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/S0264-410X(00)00457-6","article-title":"Hepatitis B: vaccination programmes in Europe\u2014an update","volume":"19","author":"Van Damme","year":"2001","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2003.11.044_BIB10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s004310050910","article-title":"Childhood immunisation in the European Union. Confederation of European Specialists in Paediatrics (CESP)","volume":"157","author":"Helwig","year":"1998","journal-title":"Eur. J. Pediatr."},{"issue":"7024","key":"10.1016\/j.vaccine.2003.11.044_BIB11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/bmj.312.7024.160","article-title":"Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme","volume":"312","author":"Hargreaves","year":"1996","journal-title":"Br. Med. J."},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2003.11.044_BIB12","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S0264-410X(98)00426-5","article-title":"Development and clinical application of new polyvalent combined paediatric vaccines","volume":"17","author":"Andre","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.044_BIB13","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0264-410X(03)00107-5","article-title":"Development and clinical testing of multivalent vaccines based on a diphtheria\u2013tetanus\u2013acellular pertussis vaccine: difficulties encountered and lessons learned","volume":"21","author":"Capiau","year":"2003","journal-title":"Vaccine"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2003.11.044_BIB14","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/S0264-410X(98)00422-8","article-title":"New acellular pertussis-containing paediatric combined vaccines","volume":"17","author":"Pines","year":"1999","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2003.11.044_BIB15","doi-asserted-by":"crossref","first-page":"E52","DOI":"10.1542\/peds.102.5.e52","article-title":"Report of a US public health service workshop on hypotonic\u2013hyporesponsive episode (HHE) after pertussis immunization","volume":"102","author":"Braun","year":"1998","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.vaccine.2003.11.044_BIB16","doi-asserted-by":"crossref","first-page":"E52","DOI":"10.1542\/peds.106.4.e52","article-title":"Hypotonic\u2013hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996\u20131998","volume":"106","author":"DuVernoy","year":"2000","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.vaccine.2003.11.044_BIB17","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/00006454-199712000-00004","article-title":"Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b\u2013etanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccine","volume":"16","author":"Dagan","year":"1997","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.044_BIB18","first-page":"157","article-title":"Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in healthy adolescents on two-dose schedule","volume":"40","author":"Chen","year":"1999","journal-title":"Acta Paediatr. Taiwan"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2003.11.044_BIB19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0264-410X(00)00231-0","article-title":"A new DTPa\u2013HBV\u2013IPV vaccine co-administered with Hib, compared to a commercially available DTPw\u2013IPV\/Hib vaccine co-administered with HBV, given at 6, 10 and 14 weeks following HBV at birth","volume":"19","author":"Gylca","year":"2000","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.044_BIB20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/infdis\/161.3.487","article-title":"Natural history of pertussis antibody in the infant and effect on vaccine response","volume":"161","author":"Van Savage","year":"1990","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.044_BIB21","unstructured":"International conference on harmonization (ICH): note for guidance on statistical principals of clinical trial (E9). CPMP\/ICH\/363\/96, adopted March 1998."},{"issue":"5","key":"10.1016\/j.vaccine.2003.11.044_BIB22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0022-3476(96)70152-X","article-title":"Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants","volume":"129","author":"Schmitt","year":"1996","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.044_BIB23","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1067\/mpd.2000.107796","article-title":"Primary vaccination of infants with diphtheria\u2013tetanus\u2013acellular pertussis\u2013hepatitis B virus-inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections","volume":"137","author":"Schmitt","year":"2000","journal-title":"J. Pediatr."},{"key":"10.1016\/j.vaccine.2003.11.044_BIB24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0264-410X(01)00344-9","article-title":"Large scale safety study of a liquid hexavalent vaccine (D\u2013T\u2013acP\u2013IPV\u2013PRP\u223cT-HBs) administered at 2, 4, 6 and 12\u201314 months of age","volume":"20","author":"Liese","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.044_BIB25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.109.4.e58","article-title":"Safety and reactogenicity of a novel DTPa\u2013HBV\u2013IPV combined vaccine given along with commercial Hib vaccines in comparison with separate concomitant administration of DTPa, Hib, and OPV vaccines in infants","volume":"109","author":"Zepp","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2003.11.044_BIB26","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/00006454-200110000-00011","article-title":"Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infants","volume":"20","author":"Yeh","year":"2001","journal-title":"Pediatr. Infect. Dis."},{"issue":"9195","key":"10.1016\/j.vaccine.2003.11.044_BIB27","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(99)04377-9","article-title":"Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria\u2013tetanus\u2013pertussis containing acellular pertussis","volume":"354","author":"Eskola","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.044_BIB28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1185\/03007990152673837","article-title":"Haemophilus influenzae type b vaccine: reconstitution of lyophilised PRP-T vaccine with a pertussis-containing paediatric combination vaccine, or a change in the primary series immunisation schedule, may modify the serum anti-PRP antibody responses","volume":"17","author":"Vidor","year":"2001","journal-title":"Curr. Med. Res. Opin."},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2003.11.044_BIB29","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/S0264-410X(00)00517-X","article-title":"Clinical relevance of lower Hib response in DTPa-based combination vaccines","volume":"19","author":"Poolman","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.044_BIB30","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00006454-200106000-00008","article-title":"Early responses to nonconjugated polyribosylribitol phosphate challenge as evidence of immune memory after combined diphtheria\u2013tetanus\u2013pertussis\u2013polio\u2013Haemophilus influenzae type b primary vaccination","volume":"20","author":"Dagan","year":"2001","journal-title":"Pediatr. Infect. Dis."},{"issue":"1","key":"10.1016\/j.vaccine.2003.11.044_BIB31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s004310050544","article-title":"Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib\u2013DTPa\u2013HBV combined vaccine","volume":"156","author":"Zepp","year":"1997","journal-title":"Eur. J. Pediatr."},{"issue":"8","key":"10.1016\/j.vaccine.2003.11.044_BIB32","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00006454-200108000-00010","article-title":"Haemophilus influenzae type b disease: impact and effectiveness of diphtheria\u2013tetanus toxoids\u2013acellular pertussis (inactivated poliovirus)\/H. influenzae type b combination vaccines","volume":"20","author":"Schmitt","year":"2001","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.11.044_BIB33","unstructured":"Kalies H, Meyer N, Siedler A, Schmitt HJ, von Kries R. Effectiveness of DTPa\/Hib and DTPa\u2013IPV\/Hib combination vaccines in Germany: four year follow-up. Abstract, ESPID, 2003."},{"key":"10.1016\/j.vaccine.2003.11.044_BIB34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00431-002-1079-5","article-title":"Immunogenicity and reactogenicity of a novel hexavalent DTPa\u2013HBV\u2013IPV\/Hib vaccine compared to separate concomitant injections of DTPa\u2013IPV\/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule","volume":"161","author":"Avdicov\u00e1","year":"2002","journal-title":"Eur. J. Pediatr."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03008478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03008478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T17:40:21Z","timestamp":1682617221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03008478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":34,"journal-issue":{"issue":"17-18","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0264410X03008478"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.11.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}